ExBRAC- Expressive Writing in Breast Cancer
Enrolling by invitation · Not applicable
Conditions studied: Breast Cancer
In brief
The study is a randomized trial designed to examine whether an "expressive writing" intervention can affect the quality of life in patients recently diagnosed with breast cancer. The method "expressive writing" consists of writing about the breast cancer or other related subjects during 20 minutes, once a week for four consecutive weeks. The impact on quality of life will be assessed by having participants complete questionnaires at three different time points during the study. The questionnaire will be developed using a clinimetric approach, based on semi-structured interviews with breast cancer patients. The themes emerging from these interviews will be used to formulate the questions. Additionally, well-known quality-of-life measurement instruments and registry data with clinically relevant information-such as tumor stage and treatment-will be incorporated.
Key facts
- Study ID
- NCT07298980
- Run by
- Region Skane
- People needed
- 272
- Starts
- 2026-02-01
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Planned for surgery of breast cancer without neoadjuvant treatment
You may not qualify if…
- Not able to understand Swedish
- Previous breast cancer
Where it is running
- Department of Surgery, Hospital of Helsingborg — Helsingborg, Skåne County, Sweden
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.